Curative vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
Curative is an AI-powered health insurance plan for employers that eliminates copays and deductibles; raised $153M Series B at $1B valuation; partners with employers to offer zero-cost primary and specialist care using a curated provider network.
About
Curative is a health insurance startup redesigning employer-sponsored health benefits by offering a plan that eliminates copays, deductibles, and coinsurance for employees who use Curative's curated network of primary care providers, specialists, and hospitals. Founded in 2020 in Austin, Texas by Fred Turner (who previously ran Curative's COVID testing business at massive scale), the company raised $153 million in a Series B round at a $1 billion valuation. Curative's model is built on the conviction that removing financial friction from healthcare access — specifically the upfront costs that deter people from seeking preventive and early care — ultimately reduces total healthcare spend for employers.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies;
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.